HOMEPartneringSuccess Stories
Success Stories
HEALTH MADE IN GERMANY / Germany Trade and Invest
Main Partnering Objectives:
"We wanted to build closer ties between Japan and Germany to support the creation of a strong German-Japanese trade and research network within the biotech industry.
Participants in BioJapan since 2012
Achievements:
- Held a luncheon seminar in 2017 allowing Japanese companies "to exchange ideas with representatives from Germany’s unique medical biotechnology landscape."
- Extended bilateral German-Japanese networks, paving the way for German-Japanese biotech SME partnerships.
- "We are still in contact with about 20 companies we met at BioJapan 2017, which showed a high interest to grow their business in Germany. Our experts will support them from the decision-making phase to market entry, right up to setting up in Germany."
- Set to establish a German Pavilion in 2018, "which will provide for the first time a common platform for German exhibitors under the umbrella of "Made in Germany."
Berlin Partner / Cluster HealthCapital Berlin
Participants in BioJapan since 2012
Main Partnering Objectives:
“Building bridges between Japan and Berlin when it comes to research collaboration or market access – for the SMEs in our cluster and Japanese companies with an interest in the EU market.”
Achievements:
“Our networks have been steadily growing. We were able to build good relations with influential Japanese clusters and initiatives. Those contacts have already helped our companies to engage in partnerships in Japan.”
Sphere Fluidics Ltd. (via the EU-Japan Centre for Industrial Cooperation)
First participated in BioJapan 2016
Main Partnering Objectives:
“To learn more about the Japanese pharmaceutical market and to find a distributor.”
Achievements:
- Identified 5 potential distributors and already set to sign up two of them.
- Learned more about the Japanese market and identified sales leads
- Will launch new single cell analysis system (Cyto-Mine®) in Japan in May 2017.
Proteo-Science Center, Ehime University (Protein Island Matsuyama Project)
- Continuous participation in BioJapan from 2013-2016. Booth presentation organized by collaboration of Ehime Univ., Ehime Prefecture & CellFree Sciences Co., Ltd.
- Forged two research partnerships with a domestic chemical company and a global pharmaceutical company.
- Developed new protein expression kit based on collaboration between CellFree Sciences and a domestic chemical company.
- Announced technical lecture course in presenter seminar, and obtained new participants.
“The matching system and partnering events, provided by BioJapan, gave us chance to appeal our technologies and seeds to pharmaceuticals and industries. Scientists in Ehime University attended discussions with business partners, and explained their technologies by themselves. It contributed to benefit both academia and company sides”.
Director, Proteo-Science Center
Takafumi TSUBOI
Commercialization and the product sold:
Cell-Free Membrane Protein Production System
Membrane proteins are an important drug target. We developed a new method to synthesize membrane proteins in vitro. Large amount of membrane proteins can be synthesized in a short time with high success rate, and it is useful to prepare immunizing antigen for antibody development against membrane proteins. A cell-free membrane protein synthesis kit based on our technology is available from CellFree Sciences. Many global and domestic companies introduced the kit.
